Investment in Innovation Key to Achieving Sustainable Development Health Goals 09/12/2022 Megha Kaveri The world can achieve the global health goals of the Sustainable Development Agenda 2030 only if it makes focussed investments into health innovation in the coming years. This was a key message from parliamentarians and representatives of the global health agency, UNITAID, at a panel on “Achieving the Global Health Targets Through Equitable Access to […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> From COVID to Humanitarian Crises – Medical Oxygen Needs More Prioritization for its Lifesaving Capacities 17/03/2022 Raisa Santos From patients lying in the parking lots of hospitals, in the back seats of cars suffocating as their family members searched frantically for oxygen in India during its second wave of COVID last year, to the inability to receive emergency care amidst constant bombing and shelling in current war-torn Ukraine, global health experts and leaders […] Continue reading -> ‘Code Red’ Oxygen Shortages in 32 Countries; But with Finance Available Countries Need to Step up to Bat 02/09/2021 Madeleine Hoecklin As some 32 countries worldwide, including seven African nations, face “code red” oxygen shortages, WHO and its partners are in the midst of a major effort to recruit sufficient supplies to meet countries’ urgent needs for life-saving oxygen. But while over US$500 million is now available in funds and finance for oxygen through the Access […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> From COVID to Humanitarian Crises – Medical Oxygen Needs More Prioritization for its Lifesaving Capacities 17/03/2022 Raisa Santos From patients lying in the parking lots of hospitals, in the back seats of cars suffocating as their family members searched frantically for oxygen in India during its second wave of COVID last year, to the inability to receive emergency care amidst constant bombing and shelling in current war-torn Ukraine, global health experts and leaders […] Continue reading -> ‘Code Red’ Oxygen Shortages in 32 Countries; But with Finance Available Countries Need to Step up to Bat 02/09/2021 Madeleine Hoecklin As some 32 countries worldwide, including seven African nations, face “code red” oxygen shortages, WHO and its partners are in the midst of a major effort to recruit sufficient supplies to meet countries’ urgent needs for life-saving oxygen. But while over US$500 million is now available in funds and finance for oxygen through the Access […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
From COVID to Humanitarian Crises – Medical Oxygen Needs More Prioritization for its Lifesaving Capacities 17/03/2022 Raisa Santos From patients lying in the parking lots of hospitals, in the back seats of cars suffocating as their family members searched frantically for oxygen in India during its second wave of COVID last year, to the inability to receive emergency care amidst constant bombing and shelling in current war-torn Ukraine, global health experts and leaders […] Continue reading -> ‘Code Red’ Oxygen Shortages in 32 Countries; But with Finance Available Countries Need to Step up to Bat 02/09/2021 Madeleine Hoecklin As some 32 countries worldwide, including seven African nations, face “code red” oxygen shortages, WHO and its partners are in the midst of a major effort to recruit sufficient supplies to meet countries’ urgent needs for life-saving oxygen. But while over US$500 million is now available in funds and finance for oxygen through the Access […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Code Red’ Oxygen Shortages in 32 Countries; But with Finance Available Countries Need to Step up to Bat 02/09/2021 Madeleine Hoecklin As some 32 countries worldwide, including seven African nations, face “code red” oxygen shortages, WHO and its partners are in the midst of a major effort to recruit sufficient supplies to meet countries’ urgent needs for life-saving oxygen. But while over US$500 million is now available in funds and finance for oxygen through the Access […] Continue reading -> Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Forty New Medicines & 16 New Indications Under Consideration For WHO Essential Medicines List 21/06/2021 Elaine Ruth Fletcher Proposals to incorporate some 40 new medications in WHO’s Essential Medicines List – from complex cancer treatments to new medicines for hepatitis C and rabies – will be examined over the coming two weeks by the EML Expert Committee. The Committee, which kicked off its deliberations on Monday with a public hearing, also will consider […] Continue reading -> Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unitaid Commemorates World Chagas Day With New Initiative To Prevent Mother-To-Child Transmission 15/04/2021 Editorial team In commemoration of World Chagas Disease Day, Unitaid and the Brazilian Ministry of Health launched a $19 million initiative to expand access to affordable diagnostics and treatments for women and newborns in four Latin American countries where Chagas disease is endemic – Brazil, Bolivia, Colombia, and Paraguay. Transmitted by the blood-sucking triatomine bug called Trypanosoma […] Continue reading -> Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unitaid Funded Long-Acting Medicines Centre At University Of Liverpool To Shape The Future of Treatment 12/01/2021 Raisa Santos A US$40 million research consortium has been created to repurpose existing medicines for hepatitis, tuberculosis and malaria into long-acting treatments that can benefit low- and middle-income countries (LMICs) where people often have trouble accessing medicine over and over again, Unitaid experts told Health Policy Watch. The consortium on Tuesday launched the new Centre of Excellence […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> $US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
$US 300 Million In New COVID-19 Funding Initiatives Rushed Out By Gates, France & European Commission 12/11/2020 Elaine Ruth Fletcher A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading -> $US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
$US6 Billion Basket Of Drugs Planned For Worldwide Distribution Of COVID-19 Treatments 09/11/2020 J Hacker & Elaine Ruth Fletcher A WHO co-sponsored partnership is laying the groundwork for a worldwide distribution plan of $US 6 billion worth of the most effective COVID-19 drugs, including cutting-edge monoclonal antibodies treatments if proven effective – so as to ensure that high-income countries do not snap up all available new therapies as they arrive on the market. The […] Continue reading -> Posts navigation Older posts